Atlas Trials

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

Clinical trial NCT00630799 · TERMINATED

Trial details

NCT number
NCT00630799
Sponsor
GP-Pharm
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2008-05-01
Primary completion
2009-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.